MicroRNAs in non‐small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential
Abstract Lung cancer remains the most lethal cancer among men and women in the United States and worldwide. The majority of lung cancer cases are classified as non‐small cell lung cancer (NSCLC). Developing new therapeutics on the basis of better understanding of NSCLC biology is critical to improve...
Saved in:
Main Authors: | Hannah Petrek (Author), Ai‐Ming Yu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Noncoding microRNAs: small RNAs play a big role in regulation of ADME?
by: Ai-Ming Yu, et al.
Published: (2012) -
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer
by: Yixin Chen, et al.
Published: (2023) -
Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer
by: Osama Sweef, et al.
Published: (2023) -
Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs
by: Yimei Wang, et al.
Published: (2024) -
The Therapeutic Potential of MicroRNAs in Cancer: Illusion or Opportunity?
by: Orazio Fortunato, et al.
Published: (2020)